Vectura data to be shared at ATS 2019

15th May 2019

Vectura is sharing new data at the ATS International Conference 2019 in Dallas, US.

We’re proud of our research and development, and five poster presentations will focus on our AKITA® JET smart nebuliser platform and VR647 development programme.

We will also take the opportunity to discuss the data and future projects with key opinion leaders who will be attending the congress.

ATS is one of the most important medical conferences in the respiratory calendar. Since 1905 it has grown to attract around 14,000 physicians and scientists from around the globe.

You can find details of our presentations below. On each day, the presenter will be available between 11am and 1pm to discuss the poster.

Poster 1: Sunday 19th May

Pharmacokinetics, safety and tolerability of single doses of budesonide delivered by AKITA® JET and conventional nebuliser in healthy adult volunteers and patients with asthma

Presented by Gary Burgess, VP Medical
A32 Asthma: Clinical studies II. Thematic posters: 9.15-4.15. Area E, Hall F (Level 2) KBHCCD

Poster 2: Wednesday 22nd May

Pharmacokinetics of budesonide suspension delivered by the VR647 inhalation system in paediatric patients with wheezing, reactive airway disease or mild asthma

Presented by Dr Craig LaForce, North Carolina Clinical Research
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15-3.30. Area H, Hall F (Level 2) KBHCCD

Poster 3: Wednesday 22nd May

Pharmacokinetic modelling of budesonide delivery with the VR647 inhalation system, a novel paediatric inhalation device, for Phase 3 study dose selection

Presented by Bernhard Muellinger, VP Inhalation Technology
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H, Hall F (Level 2). KBHCCD

Poster 4: Wednesday 22nd May

An open-label, non-drug study to evaluate the use of a mouthpiece with the VR647 inhalation system in patients aged less than five years

Presented by Professor Leonard Bacharier, Washington University School of Medicine
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H, Hall F (Level 2) KBHCCD

Poster 5: Wednesday 22nd May

Patient satisfaction with the VR647 inhalation system: Data from two studies in paediatric patients

Presented by Anna Ribera, Director – Medical Affairs
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H Hall F (Level 2). KBHCCD